Anxiolytics (52 results)

Condition: Very Good. Envoi rapide Très Bon Etat. in8. 1979. Cartonné jaquette. 174 pages. Very Good.

Condition: Good. American Psychiatric Association 1973 Binding: Hardcover.

cd_rom. Condition: Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority.

Taschenbuch. Condition: Neu. Neuware.

Taschenbuch. Condition: Neu. Neuware.

Condition: Bueno. Basel 1992. Karger. International Academy for Biomedical and Drug Research Vol. 3. 162 pp. 25x18. Cartoné. Texto en inglés.

Condition: New. Print on Demand.

Condition: New. Print on Demand.

Condition: New.

Condition: New.

Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.

Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Condition: New. In English.

Condition: New. In English.

Condition: New. Highlights anxiolytics, examining in details the strengths and weaknesses of different classes of proposed anxiolytics. This work is suitable for researchers in academia and the pharmaceutical industry, and also for psychiatrists and medical students interested in this specialty. Editor(s): Briley, Mike; Nutt, David J. Series: Milestones in Drug Therapy. Num Pages: 190 pages, biography. BIC Classification: MBGR; MMGW; MMH. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 12. Weight in Grams: 454. . 2000. Hardback. . . . . …

Condition: New.

Hard Cover. Condition: Very Good. No Jacket. First Edition. Technical studies (15 papers & a round-table) of drugs and other treatments for anxiety & insomnia. Hardcover, no jacket, likely as issued. Light wear, minor scuffing to covers, one corner bumped, name scrawled on free endsheet. Text clean; [6], 161 pages; index, notes, tables, figures. Size: 7" by 9¾". …

Condition: As New. Unread book in perfect condition.

Condition: Gut. Zustand: Gut | Seiten: 174 | Sprache: Deutsch | Produktart: Bücher | Keine Beschreibung verfügbar.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal.…

Condition: New. pp. 196.

Condition: New. For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have ev.

Taschenbuch. Condition: Neu. Anxiolytics | Mike Briley (u. a.) | Taschenbuch | ix | Englisch | 2012 | Birkhäuser | EAN 9783034895811 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Condition: New. Highlights anxiolytics, examining in details the strengths and weaknesses of different classes of proposed anxiolytics. This work is suitable for researchers in academia and the pharmaceutical industry, and also for psychiatrists and medical students interested in this specialty. Editor(s): Briley, Mike; Nutt, David J. Series: Milestones in Drug Therapy. Num Pages: 190 pages, biography. BIC Classification: MBGR; MMGW; MMH. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 12. Weight in Grams: 454. . 2000. Hardback. . . . . Books ship from the US and Ireland. …

Paperback. Condition: Brand New. reprint edition. 808 pages. 9.50x6.70x1.80 inches. In Stock.

Hardcover. Condition: gut. 1981. Psychotropic Agents, Part 2: Anxiolytics, Gerontopsychopharmacological Agents, and Psychomotor Stimulants (Handbook of Experimental Pharmacology. Continuation of Handbuch der experimentellen Pharmakologie, Vol. 55/II) In deutscher Sprache. pages.

Condition: gut. Anxiolytics In deutscher Sprache. pages.

Hardcover. Condition: gut. 1979. Modern Trends in Pharmacopsychiatry Differential Psychopharmacology of Anxiolytics and Sedatives In deutscher Sprache. pages.

Hardcover. Condition: Near Fine. Dust Jacket Condition: Near Fine. Book and jacket in near fine condition. 0.

Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.